Targeting ferroptosis protects against experimental (multi)organ dysfunction and deathSamya Van Coillie, Tom Vanden Berghe, Jelle Huysentruyt et al.|Nature Communications|2022Cited by 176
Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progressionEmily Van San, Tom Vanden Berghe, Angela C. Debruyne et al.|Cell Death and Differentiation|2023Cited by 93
Ferroptosis and pyroptosis signatures in critical COVID-19 patientsCédric Peleman, Tom Vanden Berghe, Samya Van Coillie et al.|Cell Death and Differentiation|2023Cited by 36
Potential of biomarker-based enrichment strategies to identify critically ill patients for emerging cell death interventionsCyril Willemart, Tom Vanden Berghe, Ruth Seurinck et al.|Cell Death and Differentiation|2025Cited by 8
Targeting ferroptosis protects against multiorgan dysfunction and death.Tom Vanden Berghe, Koen Augustyns, Samya Van Coillie et al.|Research Square|2021Cited by 1